Head-to-head
Noom Med vs TMates
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. Noom Med is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Noom Med is $199 a month all-in for semaglutide; TMates is $249. Over twelve months that is $2,388 against $1,896. Value Scores are 73.1 and 51.8 out of 100.
Semaglutide
Plan pages: Noom Med plans · TMates plans
At 2.4 mg/week, Noom Med is $199 a month all-in and TMates is $249 — $50 apart, or $600 across a year. Over twelve months the totals are $2,388 (billed monthly) and $1,896 (prepaid term).
Noom Med charges a flat $199 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
TMates charges a flat $249 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
| Dose | Noom Med | Rank | TMates | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $199 | 17/32 | $249 | 23/32 | Noom Med by $50 |
| 0.5 mg | $199 | 12/21 | — | — | only Noom Med publishes |
| 1 mg | $199 | 12/21 | — | — | only Noom Med publishes |
| 1.7 mg | $199 | 12/21 | — | — | only Noom Med publishes |
| 2.4 mg | $199 | 14/29 | $249 | 19/29 | Noom Med by $50 |
Noom Med is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Noom Med sits 10 of 29 on all-in monthly cost and TMates sits 16. There are 5 other programs priced between them. The field median is $249 and the floor is $129, so both sit below the median. Noom Med is $70 above the cheapest semaglutide program on record. TMates is $120 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Noom Med undercuts it by $150, TMates by $100. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Noom Med | TMates | Cheaper |
|---|---|---|---|
| Month to month | $199 | $249 | Noom Med by $50 |
| 12-month term | — | $158 | only TMates publishes this term |
| Settled dose | Noom Med | TMates | Difference |
|---|---|---|---|
| 0.25 mg | $2,388 | $2,988 | $600 apart |
| 0.5 mg | $2,388 | — | one side unpriced |
| 1 mg | $2,388 | — | one side unpriced |
| 1.7 mg | $2,388 | — | one side unpriced |
| 2.4 mg | $2,388 | $2,988 | $600 apart |
Noom Med publishes no rate for 3-month term, 6-month term, 12-month term; TMates publishes none for 3-month term, 6-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $2,388 on Noom Med and $2,988 on TMates. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: TMates publishes no price at 3 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 73.1 for Noom Med and 51.8 for TMates, against a semaglutide category floor of $129. Noom Med leads by 21.3 points, and the margin comes from structure rather than price alone.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Noom Med | 45.4 | 12.8 | 10 | 5 | 73.1 |
| TMates | 36.3 | 10.5 | 0 | 5 | 51.8 |
Where the two programs differ
All-in monthly
Noom Med is cheaper month to month — $199 against $249, a gap of $50 every month, or $600 across a year if both rates hold.
Cancellation terms
Cancellation differs: Noom Med states Per plan terms, while TMates states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Noom Med asks for Program-based; TMates asks for 12-month plan or month-to-month; substantial difference in rates. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Noom Med charges one price at every dose; TMates prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Noom Med's figure is provider-stated and TMates's is reported. Noom Med rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $2,388 for Noom Med and $1,896 for TMates. TMates is lower by $492 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Noom Med Official site
Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
It names its compounding pharmacy — Partner pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — noom.com program page capture 2026-08-08
Watch: Noom's program bundling changes frequently; confirm what the quoted figure includes.
TMates Official site
TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are 12-month plan or month-to-month; substantial difference in rates; cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Which molecules each one carries
Noom Med carries semaglutide at $199 a month; does not offer tirzepatide.
TMates carries tirzepatide at $297 a month and semaglutide at $249 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Noom Med does not publish
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
TMates does not publish
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask Noom Med and TMates for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. TMates carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. TMates publishes a twelve-month rate of $158 a month against $249 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Noom Med Official site wins this matchup. If you expect to titrate to the top of the ladder, noom med's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, noom med's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Noom Med's semaglutide price is provider-stated as of 2026-08-08; TMates's is reported as of 2026-07-14.
Questions
Is Noom Med or TMates cheaper for semaglutide?
Noom Med is cheaper on all-in monthly cost at 2.4 mg/week: $199 against $249, a difference of $50 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Noom Med versus TMates?
Noom Med works out to $2,388 across twelve months and TMates to $1,896, on the plan terms each publishes.
Does Noom Med or TMates raise the price as the dose goes up?
Noom Med: no, it charges one flat rate at every dose. TMates: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Noom Med and TMates differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Noom Med and TMates names its pharmacy?
Noom Med does — Partner pharmacies. TMates does not, recording only Partner 503A pharmacy (not publicly named), so who makes its medication cannot be independently verified.
How well evidenced are the Noom Med and TMates prices?
Noom Med's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. TMates's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Noom Med official site · TMates official site. Compounded tirzepatide and semaglutide are not FDA-approved products.